ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effect of oridonin on oxylipins in the livers of mice with acute liver injury induced by D-galactosamine and lipopolysaccharide

Zhan, Zhikun; Zhang, Tao; Dai, Fahong; Wen, Xin; Chen, Yulian; Jiang, Huanguo; Gu, Tanwei; Cheng, Yuan*; Tang, Lan*南方医科大学; y
International Immunopharmacology2022-1DOI: 10.1016/j.intimp.2021.108387
5被引6阅读
引用收藏
分享

摘要

Background and Purpose: Oridonin (Ori) has been shown to protect against acute liver injury (ALI) induced by D-galactosamine (D-GalN) and lipopolysaccharide (LPS). Oxylipins are oxidation products of polyunsaturated fatty acids (PUFAs) and are key proinflammatory mediators. This study aimed to investigate the changes in oxylipins in the livers of mice with D-GalN/LPS-induced ALI and the effects of Ori on these changes. @@@ Results: 54 oxylipins in liver tissues were identified and qualitatively and quantitatively analyzed by ultra-performance liquid chromatography-electrospray ionization triple quadrupole mass spectrometry (UPLC-QTRAP/MS/MS). The levels of 12-HETE, 12-HEPE, 14(S)-HDHA, PGE2, dihomo-gamma-linolenic acid and 13-HOTrE in the liver were significantly increased in the D-GalN/LPS-induced ALI group compared with the control group, and the levels of EPA and 7-HDHA were significantly decreased. However, pretreatment with Ori dramatically decreased the levels of 12-HETE, 12-HEPE, 14(S)-HDHA, PGE2 and 13-HOTrE compared with those of the ALI group and induced 7-HDHA and 15-oxoETE. Moreover, Ori reduced the protein levels of COX-1, COX-2, ALOX5, ALOX12 and ALOX15 induced by D-GalN/LPS, indicating that Ori altered oxylipins through the COX and LOX pathways. @@@ Conclusions: These results suggest that the protective effect of Ori on ALI is partly mediated by affecting the oxylipin pathway.

学科与关键词

关键词
OridoninOxylipinAcute Liver InjuryD-galactosamineLipopolysaccharide
相关
加载中…
  • Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasome
    Zhang, Tao; Chen, Yulian; Zhan, Zhikun; Mao, Zhihao; Wen, Yu; Liu, Shuwen; Tang, Lan*DRUG DEVELOPMENT RESEARCH, 2021, 82(4): 575-580.被引 10
  • Oridonin restores hepatic lipid homeostasis in an LXRa-ATGL/EPT1 axis-dependent manner
    Chen, Yulian; Jiang, Huanguo; Zhan, Zhikun; Lu, Jindi; Gu, Tanwei; Yu, Ping; Liang, Weimin; Zhang, Xi; Zhong, Shilong; Tang, Lan*Journal of Pharmaceutical Analysis, 2023, 13(11): 1281-1295.
  • Oridonin alleviates hyperbilirubinemia through activating LXRα-UGT1A1 axis
    Zhan, Zhikun; Dai, Fahong; Zhang, Tao; Chen, Yulian; She, Jianglian; Jiang, Huanguo; Liu, Shuwen; Gu, Tanwei; Tang, Lan*Pharmacological Research, 2022, 178: 106188.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2022-01
卷期
第 102 卷
页码
108387
DOI
10.1016/j.intimp.2021.108387
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81973388, 81600489]; Marine Economy Development Project of Guangdong Province [GDNRC202152]; Major Scientific and Technological Projects of Guangdong Province [2019B020202002]

作者

  • Z

    Zhan, Zhikun (第一作者)

    new · southern med univ

  • Z

    Zhang, Tao

    guangzhou women & childrens med ctr

查看全部 9 位作者收起作者
  • D

    Dai, Fahong

    new · southern med univ

  • W

    Wen, Xin

    southern med univ

  • C

    Chen, Yulian

    new · southern med univ

  • J

    Jiang, Huanguo

    new · southern med univ

  • G

    Gu, Tanwei

    new · southern med univ

  • C

    Cheng, Yuan (通讯)

    new · southern med univ · 2

  • T

    Tang, Lan (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417